CI Investments Inc
PTCT icon

CI Investments Inc’s PTC Therapeutics PTCT Stock Holding History

CI Investments Inc’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,385
Closed -$71K – 1330
2025
Q1 		$71K Sell
1,385
-7
-0.5% -$349 ﹤0.01% 997
2024
Q4 		$63K Sell
1,392
-551
-28% -$23.6K ﹤0.01% 1012
2024
Q3 		$72K Buy
1,943
+15
+0.8% +$502 ﹤0.01% 941
2024
Q2 		$59K Sell
1,928
-1,457
-43% -$47.2K ﹤0.01% 941
2024
Q1 		$98K Buy
3,385
+3
+0.1% +$84 ﹤0.01% 900
2023
Q4 		$93K Buy
+3,382
New +$77.3K ﹤0.01% 848

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CI Investments Inc's PTCT Position: Q2 2025 in Review

CI Investments Inc sold out of PTC Therapeutics (PTCT) in Q2 2025, closing a stake of 1,385 shares — an estimated $71K sold.

CI Investments Inc first reported a position in PTCT in Q4 2023 and held it in 6 quarters. The position peaked at $98K in Q1 2024. 283 funds tracked by Wall St. Rank hold PTCT as of Q2 2025.

  • CI Investments Inc reported no remaining PTC Therapeutics position as of Q2 2025 after selling out during the quarter.
  • CI Investments Inc sold 1,385 PTC Therapeutics shares in Q2 2025, an estimated $71K.
  • CI Investments Inc first reported a position in PTC Therapeutics in Q4 2023 and held it in 6 quarters.
  • CI Investments Inc's PTC Therapeutics position peaked at $98K in Q1 2024.
  • 283 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2025.

Based on CI Investments Inc's 13F filing for Q2 2025, filed 12 Aug 2025.